AHL
RNAM

Abel Hall LLC’s Avidity Biosciences RNAM Stock Holding History

Abel Hall LLC’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,596
Closed -$620K – 945
2025
Q4 		$620K Buy
+8,596
New +$555K 0.14% 117

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Abel Hall LLC's RNAM Position: Q1 2026 in Review

Abel Hall LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 8,596 shares — an estimated $620K sold.

Abel Hall LLC first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $620K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Abel Hall LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 8,596 Avidity Biosciences shares in Q1 2026, an estimated $620K.
  • Abel Hall LLC first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Abel Hall LLC's Avidity Biosciences position peaked at $620K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.